Analyst
361 Capital
Equibles does not estimate personal net worth.
Malik Varya is recorded as Analyst at 361 Capital. Malik Varya has spoken on 1 earnings call across 1 company, most recently for IOL Chemicals and Pharmaceuticals Limited on May 22, 2026. The companies whose calls Malik Varya spoke on are classified in the Healthcare sector.
“So, we've seen growth across chemicals and pharma segment. So, in terms of products which you mentioned, paracetamol, clopidogrel, pantograzole, metformin.”
361 Capital
Analyst
Transcript header (unverified)
IOL Chemicals and Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended March 31, 2026
IOL Chemicals and Pharmaceuticals Limited
